How Packaging Provides a Competitive Advantage to Ensuring Supply Chain Integrity

Wednesday, October 16 2013
8:00 am – 5:00 pm

This event was posted by NSF Pharmalytica Services

Location: NSF-DBA Boston Office - 129 South Street, Boston MA 02111

Morning Session: Packaging Anti-Counterfeiting Measures

Packaging provides a good location for both detection of counterfeit product and application of anti-counterfeiting measures.  Since addition of anti-counterfeiting measures can involve significant expense and potential disruption of the supply chain, it is important that decisions on adding such features are carefully planned before implementation.  Selection must involve technical experts but must also be supported by management and quality.

This course will provide an overview of the current situation regarding counterfeit pharmaceutical products and a discussion of the use of packaging in detecting counterfeit products, including recent discussions regarding serialization. It will then consider reasonable expectations for an anti-counterfeiting program, types of technologies available, where they are most appropriately used and what types of protection the features will provide.

Afternoon Session: Packaging Component Supplier Assurance

Packaging components provide a critical part of the pharmaceutical product delivered to the patient or health care provider.  It is important that suppliers of packaging materials, particularly product contact and printed materials, are carefully chosen. 

This course will first discuss key points for a packaging vendor qualification program.  Secondly, it will review specific issues on printed packaging materials, including fundamental information on printing technology, leading to a discussion of the cost of errors, where errors occur, and how they may be prevented or detected.  This section will include hands-on exercises to provide attendees with the knowledge to work with printed packaging vendors and respond appropriately to issues with printed materials that can potentially lead to costly recalls.

Share MassBio

 

EvaluatePharma

 

MassBio